Historique de carrière de Michael M. Mueller
Anciens postes connus de Michael M. Mueller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/05/2020 | 01/01/2022 |
| HISTOGEN INC. | Conseiller Juridique Général | 01/01/2013 | - |
| Secrétaire Général | 01/01/2013 | - |
Formation de Michael M. Mueller
| University of Minnesota | Undergraduate Degree |
| Thomas Jefferson School of Law | Graduate Degree |
| San Diego State University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| General Counsel | 2 |
| Corporate Secretary | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Michael M. Mueller
- Expérience
